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ABSTRACT
BACKGROUND
Esophageal cancer (EC) stands the 6th most frequent cause of death due to cancer worldwide.
It is mainly classified into mainly Esophageal squamous cell carcinoma (ESCC) and
Esophageal adenocarcinoma (EAC). The incidence extends from Eastern to Central Asia.
Although there are advances in the management and treatment of EC patients, the general
outcome is very poor. It is mainly because of the diagnosis during its advanced stages and
due to the absence of early clinical symptoms. Therefore, it is an important health challenge
.A clear picture regarding the risk factors and other patient demographics may help to
improve the management of the condition.

NEED FOR THE STUDY
EC is often of sudden onset and poor prognosis. It is often detected at advanced disease stage
leading to poor treatment outcome and high morbidity and mortality. An improved
understanding of the epidemiology, socio-demographics and the risk factors could aid timely
diagnosis and management by endoscopic methods or other less invasive methods or
procedures resulting in improved treatment outcomes.

METHODOLOGY
The study is a single centered retrospective study conducted in Kasturba Hospital (KH),
Manipal. Duration was 9 months (August 2018 to April 2019). Study group consisted of
patients admitted during the months of January 1 2012 till April 11 2018. Pediatric
population was excluded from the study. Sources of study include patient medical records
and hospital database for discharge summary.

RESULTS
A total of 443 patient medical records were reviewed retrospectively. Occupation and low
socio-economic status have an important association with EC. We have found that among
patients, majority belonged to two categories, Agriculturists and Homemakers. Although the
women populations were non-smokers they might have been largely exposed to passive
9

smoking, smoke and fume exposure as they use cow-dung, firewood, coal etc. as fuels for
cooking.
Alcohol intake and smoking are established risk factors for the development of EC. Most of
the patients presented with the symptoms of dysphagia, weight loss and Cough. Most
common symptoms affecting the quality of life among patients with EC were found to be
dysphagia and eating disorders.
These patients had multiple co-morbidities among which most had Hypertension, Diabetes
Mellitus Type 2 (T2DM) and Asthma. Hyperglycemia is said to promote cancer cell growth.
In this study we found that most of the patients were diagnosed with ESCC and studies
conducted in Karnataka suggests that ESCC is the most frequently occurring cancer.

CONCLUSION
In the study, we reviewed a total of 443 patient medical records and observed the influence of
Age, Gender, Body Mass Index (BMI), Social Habits, and Occupation in EC patients in
particular regions of Karnataka. The risk factors were assessed individually to determine the
effect of each in the development of EC in which we found that age, BMI, smoking, alcohol,
tobacco chewing had a significant effect on EC. We also studied the effects of Hemoglobin
(Hb), White Blood Cells (WBC), Erythrocyte Sedimentation Rate (ESR), Glycosylated
Hemoglobin (Hba1c), and Fasting Blood Glucose (FBS) in EC patients. It was found that the
most common type of EC was ESCC and that it was present mostly in the middle and lower
thirds of the esophagus.
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INTRODUCTION
Esophageal cancer (EC) stands the sixth most frequent cause of death due to cancer all over
the world because of its hostile nature leading to poor survival rate.[1] The occurrence of EC
is significantly different all over the globe. According to International Agency for Research
on Cancer (IARC) in in the year 2012, there were around 450,000 cases of EC comprising of
88% of Esophageal Squamous Cell Carcinoma (ESCC) and 12% of Adenocarcinoma (AC).[6]
ESCC is highly prevalent in region in East Asia followed by eastern and southern Africa, and
southern Europe. It is evident that culture, genetic factors, and lifestyle play a vital role in the
development of ESCC due to the geographical differences.[4] In 2013 there were 442,000
diagnoses of the disease worldwide, and 440,000 deaths due to the disease, indicating high
mortality associated with an EC diagnosis.[2] Although there are advancements in the
management and treatment of EC patients, the general outcome is found to be very poor. It is
mainly because of the diagnosis during its advanced stages and due to the absence of early
clinical symptoms.[3] Therefore, it is an important health challenge. A clear picture regarding
the risk factors and other patient demographics will help improve the management of the
condition.[1]
Distribution Worldwide:
Studies show the highest incidence of EC extend from Asia (Eastern and Central), with the
second highest incidence in coast of Africa along the Great Rift Valley and the third highest
incidence was found to be around Uruguay in South America. In North Central Taihung, in
China; ESCC incidence rates exceeds 125/100,000 per year and is the leading cause of death
in the region. Although, ESCC reports have been decreasing in countries like the United
States, Europe, Australia and many other western countries whereas it is still highly
significant in Eastern Europe, Japan and South America.[6]
Prevalence In India
India being a developing country, the varying degrees of population genetics, environments
and lifestyles, leads to a diverse distribution of disease burden and health status. In India,
there was 37, 000 (95% UI 36 000–38 000) EC cases reported in 2016, out of which 60·80%
were males. The disability-adjusted life-years (DALYs) estimated by Global Disease Burden
(GBD) 2016 shows that among all the cancers EC had caused (4.3%) of the DALYs. The
11

north-east states of Assam, Nagaland, Mizoram, and Meghalaya with the highest rates of
DALYs.[5]

Fig:1 Standardized incidence and mortality rates from esophageal cancer in Asia in 2012.
(extracted from GLOBALCAN 2012, http://globocan.iarc.fr)[35]
Histological Types
The main histological types of EC are – Esophageal Squamous Cell Carcinoma (ESCC) and
Esophageal Adenocarcinoma (EAC) – and the distribution of both varies in different
countries worldwide. The is a majority of AC reported in countries like Western Europe, U.K
and U.S.A moving ESCC to second place. Also, in our study population, we have found
ESCC to be more common than AC. There is also Barrett’s Esophagus which is found to be a
serious complication of Gastro Esophageal Reflux Disease (GERD) and increases the risk of
developing EAC. Early identification of risk factors and implementation of effective post
diagnosis intervention could help in the effective screening for Barrett's Esophagus.[3]
Risk Factors
The risk factors associated with ESCC are highly dependent on the population and the
geographical differences. In western countries, tobacco smoking, alcohol consumption and a
diet deficit of fruits and vegetables were found to be the major risks factors whereas in China
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(in regions of high incidence), studies proved that tobacco had little or less role in the
development of ESCC. [6]
1) Age & Gender: Age group above 40 and male sex are predominant risk factors of ESCC.
2) Socioeconomic Status (SES): It is one among the most consistent risk factors of ESCC.
Other factors like education, income, family history all come under SES. These factors vary
in different countries.
3) Tobacco: All forms of tobacco such as hookah, cigar, pipe and chewing tobacco are major
risk factors mainly among economically developed countries. Studies have shown that
chewing tobacco poses a bigger risk of cancer than cigarettes. The combined effect betel quid
and tobacco chewing increased relative risk by 2.3- to 3.5 fold when compared to betel quid
alone. Usually, tobacco chewers are also smokers leading to synergistic effects on ESCC risk.
In case of tobacco smoking, the exposure and intensity are important to determine the risk.
The nitrosamines and polycyclic aromatic hydrocarbons (PAH) present in the tobacco are
carcinogenic substances.[6]
4) Alcohol Consumption: It increases the risk for ESCC because of a compound called
Acetaldehyde, which is the first metabolite of ethanol metabolism and is a well- known Class
I carcinogen. In Asian countries, like China, Japan, Iran and India there is a 1.6 to 5.3-fold
increased risk for developing ESCC due to alcohol consumption.[6]
5) Diet: Increased consumption of raw fruits and vegetables have reduced the risk of ESCC
by 24% and 12% respectively.[6]
6) Body Mass Index: Obesity has been strongly associated as risk in case of EAC. There are
two proposed mechanisms for the same, first is a physical mechanism suggesting increased
incidence of GERD, and another mechanism suggests involvement of hormonal mechanism
facilitated by inflammatory markers secreted by adipocytes.[1]
Clinical Presentation
ESCC and EAC usually present with progressive dysphagia, odynophagia, breathing
difficulty, weight loss and chest pain and less commonly emesis, gastrointestinal bleeding,
palpable tumor, anemia, cough, fatigue, anorexia and hoarseness. In Barrett’s esophagus
heartburn, dysphagia are the most frequently found symptoms and less commonly chest
pain.[7]
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Diagnosis
The diagnosis of EC is commonly made by collecting samples of the esophageal mucosa by
the technique of endoscopy and analysis is carried out by a pathologist. Endoscopic
Ultrasound technique is used for the advanced staging, extent and location of the tumour and
therefore, helps determine the optimal treatment. CT scan is used to detect lymph node
involvement and distant metastases.[8]
Treatment
The most preferred surgical approach in early EC is mucosal resection/submucosal
dissection. This is done due to its high curative rates in early stages. In advanced stages of the
cancer, radical and complex surgical techniques are used along with chemotherapy and
chemo-radiotherapy. Patients who are unable to undergo surgery because of co-morbidity can
still receive chemo-radiotherapy or radiotherapy. In metastatic/inoperable EC, treatment
mostly comprises of palliative chemotherapy and radiotherapy.[8]
Need for the study
EC is often of sudden onset and poor prognosis. It is often detected at advanced disease stage
leading to poor treatment outcome and high morbidity and mortality. A better understanding
of the epidemiology, socio-demographics and the risk factors could aid in early diagnosis and
treatment by endoscopic methods or other less aggressive techniques. As a result, we could
improve treatment outcomes.[1]
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OBJECTIVES
Primary Objectives
• To retrieve epidemiological data and disease pattern on EC in a tertiary care hospital in
Karnataka.
• To study clinical presentation, biochemical changes in EC.
• To study the various risk factors, morbidity pattern of EC.

Secondary Objectives
• To improve treatment outcomes through a better understanding of the sociodemographic risk factors.
• To help in early diagnosis and prognosis of EC.
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METHODOLOGY
Study Site
The study was conducted retrospectively in KH, Manipal.
Study Design
Single centred retrospective study.
Study Duration
9 months (August 2018 to April 2019)
Ethical Approval
The ethical approval for the following study was taken from Institutional Ethics
Committee of KH, Manipal. (IEC No.392-2018)
Study Population
The study group consisted of EC patients admitted in the KH during the months of January 1
2012 till April 11 2018 under the ICD Code C15.0 (Cervical part of esophagus), C15.1
(Thoracic part of esophagus), C15.2 (Abdominal part of esophagus), C15.3 (Upper third of
esophagus), C15.4 (Middle third of esophagus), C15.8 (Overlapping lesion of esophagus),
C15.9 (Esophagus unspecified) and K 22.7 (Barett’s esophagus), who met the following study
criteria.
• Inclusion criteria : Patients admitted under the above ICD code from January 1 2012 to
April 11 2018
• Exclusion criteria : Paediatric Population.
Sources of data
Patient Medical Records , Hospital Database For Discharge Summary
Study Materials
• Databases like Pubmed, Science Direct, Medscape
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Operation modality This study was conducted in KH, super speciality tertiary care
hospital. Patient data were retrieved from their respective patient medical records. The data
collected was documented in a pre-designed case report form. The medical records were
reviewed for relevant information like patient demographics, social habits (tobacco smoking,
alcohol intake and tobacco chewing), symptoms presented on admission, type of cancer,
location of the tumour, the histology and biopsy reports and the treatment with its outcome.
The outcomes were documented and data were analysed using Statistical Package for Social
Sciences (SPSS) version 20.0 for following parameters.
I. Demographic status
• Age and Sex, Geographic Location, Body Mass Index
II. Clinical Presentation
• Dysphagia, Breathing Difficulty, Weight Loss, GERD, Acid Reflux, Chest Discomfort
III. Social History
• Smoking, Alcohol Intake and Tobacco chewing
IV. Type of Cancer and its Differentiation
• Esophageal Squamous Cell Carcinoma or Adenocarcinoma
• Level of Differentiation – Well, Moderate, Poor
V. Co-morbidities
• Lifestyle Diseases
VI. Biochemical Investigations
• Haemoglobin levels , ESR levels, WBC count, Platelet count , FBS, HbA1C
• Imaging Reports, Biopsy and Histology Reports
VII. Location
• Location of Cancer in the Oesophagus – Upper, Middle, Lower
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REVIEW OF LITERATURE
Esophageal Cancer (EC)
EC is the sixth common cause of death from cancer with high rates of incidence. There are
geographic variations across globe in EC in the United States and in small areas of Asia and
India. It is characterized by rapid development and poor prediction in most cases. The rising
incidence and poor prognosis of EC shows the need for improved detection and prediction
methods which are necessary for optimal treatment.[3] The occurrence increases with age (50–
70 years) and it is detected more frequently in males than in females. The most frequently
occurring histological type was ESCC. It is noted that there was an increase of proportion of
EAC which was 3.5% in 1985 to 17% by the year 2000. There was a 50% of proportion of
EAC in countries likes Western Europe and U.S.A. [22]
Histological Types and Risk factors
Based on their patterns of prevalence and etiology they are mainly classified into two
histologic types, ESCC and EAC. Poverty and poor oral hygiene are associated with a higher
SCC risk. In addition, there is increased prevalence of obesity (risk factor for EAC) but
decline in incidence of tobacco smoking (risk of ESCC) in the developed nations. [31]
Esophageal Squamous cell carcinoma (ESCC)
It represents 90% of all cases of EC worldwide. Factors contributing to ESCC are smoking
and alcohol consumption and are found to be more significant when combined. In 2012,
countries like Eastern and Southeast Asia had an estimated age-standardized incidence rate
which was of >13/100,000 person-years in men and >4/100,000 person-years in women and
also a rate of <5/100,000 person-years in men and women in most Western countries.
According to an analysis carried out in the year 2007 among Asian countries, the ESCC
incidence was decreasing in Singapore, Hong Kong, Israel and stable in Japan. Over the
years, the global incidence of ESCC has decreased among men. In women, the incidence
trends vary across populations, and the rates have increased in some countries.[30]
The risk factors for ESCC include poor oral hygiene, smoking, alcohol consumption,
consumption of caustic agents and nutritional deficiencies.[32, 33]

Esophageal Adenocarcinoma (EAC)
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Recent years have observed a rapid increase in the incidence of EAC in western countries.
The risk factors of EAC are mainly found to be age, male sex, obesity, gastro-oesophageal
reflux disease, smoking, and diet which is low in vegetables and fruits. According to
population-based studies, the annual risk of adenocarcinoma has variations between 0.12%
and 0.14% and also there was an incidence rate variations of 1.2 and 1.4 per 1000 personyears.[28]
Clinical presentation
Clinical presentations of ESCC and EAC include progressive dysphagia, odynophagia,
breathing difficulty, weight loss and chest pain and less commonly emesis, gastrointestinal
bleeding, palpable tumor, anemia, cough, fatigue, anorexia and hoarseness. The most
frequently found symptoms in Barrett’s esophagus are heart burn, dysphagia and less
commonly chest pain. The early marker of malignant transformation in Barrett’s esophagus
could be chronic cough due to reflux.[33]
Pathogenesis
ESCC
Alcohol consumption and use of tobacco are the major risk factors. As most studies suggest,
alcohol is one of the primary risk factor but smoking along with consumption of alcohol has
an additive effect leading to an increase in the relative risk. It was found that alcohol
decreases metabolism within the cell, reduces the detoxification function and promotes
oxidation thereby leading to damage of the cellular DNA. The hazardous carcinogens within
tobacco penetrate easily through the esophageal epithelium as alcohol acts as a solvent for fat
soluble compounds. The aromatic amines, nitrosamines, polycyclic aromatic hydrocarbons,
aldehydes and phenols are some of the hazardous carcinogens in tobacco.[19]
EAC
Around three-fourths of the time, it occurs mostly in distal esophagus and has a direct link to
GERD. It was found that there was a progress to Barrett’s esophagus due to untreated GERD,
where columnar epithelium replaces the stratified squamous epithelium lining the esophagus.
Two major factors that implies the pathogenesis of Barrett metaplasia leading to EAC are
chronic gastric reflux of bile at the gastro esophageal junction and the damage to the
esophagus .It is established that the effect of risk factors on the development of EC varies in
accordance with the geographical area. Different studies conducted in India on EC implies
that smoking, tobacco chewing and alcohol are the major risk factors. Presently, the most
19

common type of EC in India is ESCC and the most common location is the distal third of the
esophagus.
Data from the author’s institute (Christian Medical College Hospital, Vellore), noted that
during the period of 2010-2016, there was a total of 138 patients who underwent resection for
EC that later suggested that ESCC to be the most common histology (105 patients), as
compared to EAC (33 patients).[29]
In a case-control study conducted by Chitra S et al. (2004) in a hospital in south India,
defined the effect of alcohol, smoking and their combination along with the dietary factors in
the etiology of cancer of the esophagus that revealed the risk for esophageal cancer to be 2.5
times higher for tobacco consumers, 2.8 times higher for betel nut chewers and smokers and a
higher rate of 3.5 times with alcohol consumers.[23]
According to a case control study conducted by Ariana Znaor et al. in Chennai and
Trivandrum, South India (2003) which was performed to assess two factors; effect of
different patterns of smoking, alcohol consumption and chewing in the development
of esophageal and pharyngeal cancer and the association among these habits. The study
showed that tobacco smoking was the strongest risk factor for pharyngeal and esophageal
cancers with an odds ratio of 4.00 (95% CI 3.07–5.22) and 2.83 (95% CI 2.18–3.66)
respectively.[24]
A Golestan Cohort Study conducted by Mahdi sheikh et al. reported that there is a significant
association between the individual and combined effects of the major environmental risk
factors such as opium smoking, drinking hot beverages (≥60°C), low intake of fruits and
vegetables, exposure to air pollution and drinking contaminated water.[25]
According to a study conducted by Yingsong Lin et al (2017) in high-risk areas of China,
epidemiologic evidence suggested that the major risk factors for EC in the Taihang
Mountains region were carcinogen exposure and nutritional deficiency, rather than smoking
and drinking. It is also noted that the incidence of EC in this area is among the highest in the
world.[26]
In a study by Shao-HuaXie et al.(2018), risk factors for ESCC were found to be excessive
alcohol consumption and tobacco smoking where as in case of EAC, the main risk factors
includes GERD and obesity; tobacco smoking was only a moderately strong risk factor. The
risk of both types of EC is influenced by dietary factors. The study suggested that sex
hormones also play a role in EC.[27]
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RESULTS
A single-centered retrospective study was conducted in KH to study the risk factors
associated with the development of esophageal cancer. A total of 443 patient medical records
were reviewed retrospectively for the various factors like patient demographics, social habits,
clinical presentations,diagnosis and types of treatment provided.
1.Patient Demographics:
a) Genderwise distribution :
Among 443 patients, 282 (63.7%) were males and 161 (36.3%) were females as shown in the
Fig.2 below.

161

282
Male
Female

Figure 2: Genderwise Distribution
b) Agewise distribution:
Out of 443 patients in our study population, 269 (60.7%) were in the range of 41-64 years,
149 (33.6%) patients were of the age of more than 65 years and 25 (5.6%) patients were in
the age range of 18-40 years. The mean age of the patients was 59.3±11 years as shown in
Tab.1
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Table 1: Agewise Distribution
Frequency

Percentage

18 – 40

25

5.6

41 – 64

269

60.7

>65

149

33.6

Total

443

100

c) Body Mass Index
Among 443 patients, 185 (41.8%) was found to be underweight which was found to be most
common, 177 (40%) were of normal BMI, 32 (7.2%) were found to be overweight, 9 (2%)
were found to be obese and 40 (9%) of the BMI was unrecorded to due patient inability as
described in Fig.2.
Table 2: Body Mass Index
Frequency

Percentage

Underweight

185

41.8

Normal

177

40.0

Unknown

40

9.0

Overweight

32

7.2

Obese

9

2.0

Total

443

100

d) Geographic Location
Out of 443 patients, 424 were from the state of Karnataka, out of which majority were from
these respective districts in Karnataka; 116 (27.3%) were from Udupi, 79 (18.6%) were from
Davangere, 64 (15.0%) from Shimoga, 46(10.8%) from Haveri , 35 (8.2%) from Chitradurga,
32 (7.5%) from Chikmanglur, 17 (4%) from Bellary, 12 (2.8%) from Uttar Kannada, 6
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(1.4%) from Dakshina Kannada and fewer populations (17) from the other districts as shown
in Fig.3 below

Udupi
Davangere
Shimoga
Districts

Haveri
Chitradurga
Chikkamangaluru
Bellary
Uttar Kannada
Dakshina Kannada
Other cities
0

20
40
60
80
Frequency (No of Participants)

100

120

140

Figure 3: Geographic Location
e) Occupation
Among 443 patients, 131 (29.6%) were found to be Agriculturists, 125 (28.2%) were
Homemakers, 81 (18.2%) had Unknown Occupation, 69 (15.6%) were Labourers, 8 (1.8%)
were Retired Government Employees, 8 (1.8%) were Businessmen, 5 (1.1%) were Drivers,
5(1.1%) were Fishermen, 4 (0.9%) were Teachers, 4 (0.9%) were Carpenters and 3 (0.7%)

Occupation

were Hindu Priests as shown in Fig.4.

Agriculturists
Homemakers
Unknown
Labourers
Retired Employees
Businessmen
Drivers
Fishermen
Teachers
Carpenters
Religious workers
0
50
Frequency (No. of Cases)

100

150

Figure 4: Occupation
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f) Social Habits
Out of 443 patients, 247 (55.8%) patients had no or unknown social habits (smoking, alcohol
intake, tobacco chewing), 61 (13.8%) were alcoholics and smokers, 46 (10.4%) were
smokers, 42 (9.5%) were only tobacco chewers, 18 (4.1%) were only alcoholics, 15 (3.4%)
had the habit of smoking, alcohol intake and tobacco chewing, 10 (2.3%) were alcoholics and
tobacco chewers, 4 (0.9%) were smokers and tobacco chewers as sown in Fig.5.

Unknown/No
Alcoholics + Smokers

Social Habits

Smokers
Tobacco Chewers
Alcoholics
Smokers + Tobacco Chewers +
Alcoholics
Alcoholics + Tobacco Chewers
Smokers + Tobacco Chewers
0

50

100

150

200

250

300

Frequency (No. of cases)

Figure 5: Social Habits

g) Clinical Presentation
Out of 443 patients, 388 (87.6%) had Dysphagia, 210 (47.4%) had Weight Loss, 149 (33.6%)
had Cough, 122 (27.5%) had Loss of Appetite, 98 (22.1%) had symptoms of vomiting, 85
(19.2%) had Acid Reflux, 78 (17.5%) had Breathing Difficulty, 73 (16.5%) were found to
have Chest Discomfort, 45 (10.2%) had Hoarse Voice, 43 (9.7%) had Abdominal Pain, 32
(7.2%) had odynophagia, 25 (5.6%) had Heart Burn and 7 (1.6%) had GERD as shown in
Fig.6.
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Figure 6: Clinical Presentations

h) Co-morbidities
Out of 443 of the study population, 98 (22.1%) were found to be Hypertensive, 271 were
non-hypertensive and the disease status of 72 were unknown. 61 (13.8%) had Diabetes
Mellitus, 310 were non-diabetics, and the diabetic status of 72 patients were unknown as
shown in Fig.7. Other co-morbidities were also observed like, 23 (5.2%) had Bronchial
Asthma, 18 (4.1%) had Cardiac Complications, 16 (3.6%) had COPD, 12 (2.7%) had Other
Infectious Diseases, 10 (2.3%) had Pneumonia, 7 (1.6%) had Tuberculosis and 7 (1.6%) were
found to have Other Cancers as shown in Fig.8.
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Figure 7: Co-morbidities
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Figure 8: Other Co-morbidities
i) Biochemical Investigations
1. Haemoglobin Levels
Out of 282 Males, the haemoglobin levels of 209 (74.1%) were low, 2 (0.7%) were high, 71
(25.1%) is normal. Among 161 female patients, the haemoglobin levels of 89 (55.2%) were
low, 2 (1.2%) is high, 68 (42.2%) were normal and 2 (1.2%) were unknown as shown in
Fig.9. The mean Hb of Male population was found to be 12.3±1.9. The mean Hb of Female
population was found to be 11.5±1.8.
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Figure 9: Haemoglobin Levels
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2. Erythrocyte Sedimentation Rate (ESR):
Among 282 Males, 122 (42.3%) had a high ESR level, 100 (35.4%) had no recorded levels
(unknown), 60 (21.2%) had normal ESR. In 161 Females 52 (32.2%) had a high ESR level 93
(57.7%) had no recoded levels and 16 (9.9%) had normal ESR as shown in Fig.10.
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Figure 10: Erythrocyte Sedimentation Rate

3. White Blood Cell Count (WBC)
Among 443 patients, the WBC count of 329 (74.3%) were found to be normal, 93 (21%)
were found to have a high count, 19 (4.3%) were found to have low count and 2 (0.45%) was
unknown as shown in the Fig.11.
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Figure 11: White Blood Cells
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4. Platelet Count:
Among 443 patients, 376 (84.9%) were found to have a normal count, 38 (8.6%) had a high
count and 28 (6.3%) had a low count as shown in Tab.3
Table 3: Platelet Count
Frequency

Percent

Normal

376

84.9

High

38

8.6

Low

28

6.3

Unknown

1

0.2

Total

443

100

.

5. Blood Glucose Monitoring
Among 443 patients, 310 were non-diabetics, 61 Diabetics and the diabetic status of 72
patients were unknown.



Fasting Blood Sugar (FBS)

Out of 61 diabetics, 26 (42.6%) had Uncontrolled FBS Levels, the FBS Levels of 14 (22.9%)
were unknown, 12 (19.6%) had normal FBS levels and 9 (14.7%) had Controlled FBS levels,
as shown in Fig.12.
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Figure 12: Fasting Blood Sugar


Glycosylated Haemoglobin (HbA1c)

Among the 61 diabetics, 24 (39.3%) had poorly controlled HbA1c level, the HbA1c of 13
(21.3%) patients were unknown, 13 (21.3%) were found to have normal HbA1c and 11
(18%) had well-controlled HbA1c as shown in Fig.13.
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Figure 13: Glycosylated Haemoglobin
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6. Blood Pressure (BP)
Out of 443 patients, 98 patients were found to be hypertensive, 271 were non-hypertensive
and the disease status of 72 were unknown and the mean systolic BP of the same was found
to be 129.9±16.9 and the mean diastolic BP was found to be 82.4±10.2.
j) Type Of Cancer:
Out of 443 patients, 357 (81%) were diagnosed with Squamous Cell Carcinoma, 37 (8.4%)
had Adenocarcinoma, 36 (8.1%) were found to be unknown and 10 (2.2%) were found to
have Barrettes Esophagus as shown in Fig.14

SQUAMOUS CELL
CARCINOMA
ADENO
ARCINOMA
ADENOSQUAMO
US CARCINOMA
BARRETS
OESPHAGUS

Figure 14: Types of Cancers
k) Location Of Tumour
Among of 443 patients, 124 (28%) were located in the Middle Esophagus, 123 (27.8%) were
in the Lower Esophagus, 60 (13.5%) of the tumours were found to be in the Upper
Esophagus, 30 (6.8%) were found to be in the Lower and Middle region of the Esophagus, 17
(3.8%) were present in the Middle & Upper part of the oesophagus and 89 (20%)
Unclassified location as shown in Fig 15.
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Figure 15: Location in the Esophagus
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DISCUSSION
The present study was conducted in KH, a tertiary care hospital to study the risk factors
associated with the development of EC. It was an observational study which was done
retrospectively for a period of 9 months (August 2018 – April 2019). EC is a type of cancer
with an insidious onset and very poor prognosis. Hence, it is necessary to understand the
epidemiology, socio-demographics and the various risk factors associated with EC so as to
have a better approach towards its treatment and outcome.
Our study shows that majority of the population were males. This might be because most of
the smoking population were found to be men. Among 282 males, 125 were found to be
smokers. These results are consistent with the findings from the study conducted by
Sankaranarayanan R et al. (1991) which reported that the incidence of EC was high in males
than females with ratio of 2:1.[10] A systemic search conducted by Shao-Hua Xie et al. (2016)
highlighted that tobacco smoking was more common in men than in women and therefore
was at higher risk of developing EC.[11] Studies have also supported the theory that estrogen
is a protective factor among females, estrogen inhibits ESCC growth. This anti-proliferative
effect may be due to the estrogen receptor beta expressed in ESCC, similar effects has also
been seen in EAC.[34]
The occurrence of EC was most commonly found in the age group greater than 41. It has
been reported that there is increased risk of EC diagnosis for people of age greater than 50.[10]
We have found that a majority in our study population were found to be underweight out of
which majority had ESCC. These results are similar to the study conducted by Margaret
Smith et al. (2008) which showed that in a population of Chinese men of age group 40-79,
the association of BMI and development of ESCC is inversely proportional.[18] Proving that
low BMI is associated with increased incidence of ESCC. Although, there were 8 patients
among the underweight category who had previously undergone treatment involving
chemotherapy that might have delayed the reconstruction of the obstructed GI passage
causing weight loss.[12]
Geographical distribution of EC shows distinct variation in incidence within a particular
geographical region.[10] Most of our patients were found to be from state of Karnataka, out of
which the highest number of patients were from the district of Udupi. According to a study
conducted by Akhil Kapoor et al. (2015) in India, EC is most commonly being reported in
Karnataka, Tamil Nadu, Kerala, and Assam over the last few years.[13]
31

Occupation and Low socio-economic status have important association with EC. We found
that the majority belonged to two categories, Agriculturists and Homemakers. Alcohol and
smoking is quite prevalent among farmers and people of low socio-economic status in
India.[10] Also, studies have proven positive association between high exposure to pesticides
and risk of EC (OR = 2.3, 95% CI = 0.9–5.7).[21] Although the women population were nonsmokers they might have been largely exposed to passive smoking, smoke and fumes from
fuels such as firewood , cow dung used for cooking.[15]
Alcohol intake and smoking are established risk factors for the development of EC. Among
our patients with social habits like (alcohol intake, smoking, tobacco chewing) the majority
of them comprised of patients who consume alcohol followed by smoking. Fat-soluble
compounds of the carcinogens within tobacco are solubilized by alcohol which penetrates the
esophageal epithelium causing damage.[19] Hence, alcohol and smoking have a synergistic
effect in the development of EC. According to a review by Fang-Liang Huang et al.(2018),
smoking was found to be a major cause of ESCC (OR=2.9; 95% CI, 2.1-4.1).[3] Gene
polymorphisms in certain individuals who consume alcohol and smoke also possess an
important factor for development of EC compared to the non-carriers.[9] According to a study
on risk factors of EC conducted by Sankaranarayanan R et al (1991), majority of the patients
(54.14%) were tobacco chewers followed by smokers (36.94% ) and alcoholics (21.65%).[10]
Among our patients who had T2DM, 26 had uncontrolled FBS levels and 24 had poorly
controlled HbA1c levels which can lead to poor prognosis. Hyperglycemia is said to be the
connecting bridge between DM and cancer. The risk of progression and mortality is higher
with T2DM patients, this might be because the elevated blood glucose levels promote further
growth of the cancer cells.[16]. Bo Xu et al (2017) conducted a meta-analysis which indicates
that T2DM may have an association with an increased EC risk.[17]
In this study, most of them were diagnosed with ESCC. Worldwide, it is the most common
type of EC. A retrospective study conducted by Lokesh Gowda T.G et al (2014), ESCC was
found to be the most frequently occurring type of EC in Karnataka.[14]
We found that the most frequently occurring type of EC was in the lower and middle region
of the esophagus. These results are consistent with the findings of Cancer incidence statistics
by Cancer Research UK, that showed that the largest proportion of EC occur in the lower
third with much smaller proportions in the middle and upper thirds.[20]
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CONCLUSION
In the present study we reviewed a total of 443 patient medical records and observed the
influence of age, gender, BMI, social habits, occupation in EC patients in particular
regions of Karnataka. The risk factors were assessed individually to prove the effect of
each in the development of EC. Among our study population, ESCC was more common
in males (63.7%) than females. Also the incidence of both ESCC and EAC were more
in the age group of 41-65 (60.7%). Most of our patients were underweight (41.8%)
portraying the effect of BMI in the development of EC. Social habits like tobacco
smoking, alcohol consumption and tobacco chewing were common especially in
patients who work as agriculturists and are homemakers. T2DM was found to have a
profound effect on EC because the elevated blood glucose levels further promote cancer
cell growth. The predominant type of EC was found to be ESCC. We also plan to
further investigate the statistical significance of the risk factors with a control group and
also observe the treatment pattern in these patients.
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LIMITATIONS


Conducting a retrospective study limited the validity of information required for
the analysis.



There was missing data that could not be retrieved from the patient records or
from the hospital database.

FUTURE DIRECTIONS


To continue the study further on the risk factors by collecting a control group
from the same geographical area and performing statistical analysis to prove the
significance of each of them.



To evaluate the treatment pattern of EC patients.



To assess the financial burden on the patients by conducting a cost-analysis of
the treatment provided.



To calculate the survival rate of the patients who underwent treatment in KH.
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